These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12672107)

  • 1. On the generation of catalytic antibodies by transition state analogues.
    Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J; Warshel A
    Chembiochem; 2003 Apr; 4(4):277-85. PubMed ID: 12672107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart.
    Haynes MR; Stura EA; Hilvert D; Wilson IA
    Science; 1994 Feb; 263(5147):646-52. PubMed ID: 8303271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid schemes based on quantum mechanics/molecular mechanics simulations goals to success, problems, and perspectives.
    Ferrer S; Ruiz-Pernía J; Martí S; Moliner V; Tuñón I; Bertrán J; Andrés J
    Adv Protein Chem Struct Biol; 2011; 85():81-142. PubMed ID: 21920322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
    Sakakura M; Takahashi H; Shimba N; Fujii I; Shimada I
    J Mol Biol; 2007 Mar; 367(1):133-47. PubMed ID: 17239396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of biomimetic catalysts by molecular imprinting in synthetic polymers: the role of transition state stabilization.
    Wulff G; Liu J
    Acc Chem Res; 2012 Feb; 45(2):239-47. PubMed ID: 21967389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition state stabilization and substrate strain in enzyme catalysis: ab initio QM/MM modelling of the chorismate mutase reaction.
    Ranaghan KE; Ridder L; Szefczyk B; Sokalski WA; Hermann JC; Mulholland AJ
    Org Biomol Chem; 2004 Apr; 2(7):968-80. PubMed ID: 15034619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential transition-state stabilization in enzyme catalysis: quantum chemical analysis of interactions in the chorismate mutase reaction and prediction of the optimal catalytic field.
    Szefczyk B; Mulholland AJ; Ranaghan KE; Sokalski WA
    J Am Chem Soc; 2004 Dec; 126(49):16148-59. PubMed ID: 15584751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent NAC effect in chorismate mutase reflects electrostatic transition state stabilization.
    Strajbl M; Shurki A; Kato M; Warshel A
    J Am Chem Soc; 2003 Aug; 125(34):10228-37. PubMed ID: 12926945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of formation of reactive conformers (NACs) for the Claisen rearrangement of chorismate to prephenate in water and in the E. coli mutase: the efficiency of the enzyme catalysis.
    Hur S; Bruice TC
    J Am Chem Soc; 2003 May; 125(19):5964-72. PubMed ID: 12733937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic antibodies: hapten design strategies and screening methods.
    Xu Y; Yamamoto N; Janda KD
    Bioorg Med Chem; 2004 Oct; 12(20):5247-68. PubMed ID: 15388154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical analysis of antibody catalysis.
    Hilvert D
    Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse structural solutions to catalysis in a family of antibodies.
    Gigant B; Tsumuraya T; Fujii I; Knossow M
    Structure; 1999 Nov; 7(11):1385-93. PubMed ID: 10574796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic antibodies for complex reactions: hapten design and the importance of screening for catalysis in the generation of catalytic antibodies for the NDA/CN reaction.
    DeSilva BS; Orosz G; Egodage KL; Carlson RG; Schowen RL; Wilson GS
    Appl Biochem Biotechnol; 2000; 83(1-3):195-206; discussion 206-8, 297-313. PubMed ID: 10826960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
    Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M
    J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical insights in enzyme catalysis.
    Martí S; Roca M; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    Chem Soc Rev; 2004 Feb; 33(2):98-107. PubMed ID: 14767505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preorganization and reorganization as related factors in enzyme catalysis: the chorismate mutase case.
    Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    Chemistry; 2003 Feb; 9(4):984-91. PubMed ID: 12584715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.